Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.
Identifieur interne : 003B24 ( Main/Exploration ); précédent : 003B23; suivant : 003B25Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.
Auteurs : Pierre Amarenco ; Stephen Davis ; Elizabeth F. Jones ; Ariel A. Cohen ; Wolf-Dieter Heiss ; Markku Kaste ; Cédric Laouénan ; Dennis Young ; Malcolm Macleod ; Geoffrey A. DonnanSource :
- Stroke [ 1524-4628 ] ; 2014.
Descripteurs français
- KwdFr :
- Accident vasculaire cérébral (mortalité), Accident vasculaire cérébral (traitement médicamenteux), Accident vasculaire cérébral (épidémiologie), Acide acétylsalicylique (administration et posologie), Acide acétylsalicylique (pharmacologie), Adulte d'âge moyen, Antiagrégants plaquettaires (administration et posologie), Antiagrégants plaquettaires (pharmacologie), Anticoagulants (administration et posologie), Anticoagulants (pharmacologie), Aorte thoracique (anatomopathologie), Association de médicaments, Embolie (mortalité), Embolie (traitement médicamenteux), Embolie (épidémiologie), Encéphalopathie ischémique (mortalité), Encéphalopathie ischémique (traitement médicamenteux), Encéphalopathie ischémique (épidémiologie), Femelle, Humains, Maladies de l'aorte (mortalité), Maladies de l'aorte (traitement médicamenteux), Maladies de l'aorte (épidémiologie), Mâle, Méthode en simple aveugle, Plaque d'athérosclérose (mortalité), Plaque d'athérosclérose (traitement médicamenteux), Plaque d'athérosclérose (épidémiologie), Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Ticlopidine (administration et posologie), Ticlopidine (analogues et dérivés), Ticlopidine (pharmacologie), Warfarine (administration et posologie), Warfarine (pharmacologie), Études prospectives.
- MESH :
- administration et posologie : Acide acétylsalicylique, Antiagrégants plaquettaires, Anticoagulants, Ticlopidine, Warfarine.
- analogues et dérivés : Ticlopidine.
- anatomopathologie : Aorte thoracique.
- mortalité : Accident vasculaire cérébral, Embolie, Encéphalopathie ischémique, Maladies de l'aorte, Plaque d'athérosclérose.
- pharmacologie : Acide acétylsalicylique, Antiagrégants plaquettaires, Anticoagulants, Ticlopidine, Warfarine.
- traitement médicamenteux : Accident vasculaire cérébral, Embolie, Encéphalopathie ischémique, Maladies de l'aorte, Plaque d'athérosclérose.
- épidémiologie : Accident vasculaire cérébral, Embolie, Encéphalopathie ischémique, Maladies de l'aorte, Plaque d'athérosclérose.
- Adulte d'âge moyen, Association de médicaments, Femelle, Humains, Mâle, Méthode en simple aveugle, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Études prospectives.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Anticoagulants (administration & dosage), Anticoagulants (pharmacology), Aorta, Thoracic (pathology), Aortic Diseases (drug therapy), Aortic Diseases (epidemiology), Aortic Diseases (mortality), Aspirin (administration & dosage), Aspirin (pharmacology), Brain Ischemia (drug therapy), Brain Ischemia (epidemiology), Brain Ischemia (mortality), Drug Therapy, Combination, Embolism (drug therapy), Embolism (epidemiology), Embolism (mortality), Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic (drug therapy), Plaque, Atherosclerotic (epidemiology), Plaque, Atherosclerotic (mortality), Platelet Aggregation Inhibitors (administration & dosage), Platelet Aggregation Inhibitors (pharmacology), Prospective Studies, Single-Blind Method, Stroke (drug therapy), Stroke (epidemiology), Stroke (mortality), Ticlopidine (administration & dosage), Ticlopidine (analogs & derivatives), Ticlopidine (pharmacology), Treatment Outcome, Warfarin (administration & dosage), Warfarin (pharmacology).
- MESH :
- chemical , administration & dosage : Anticoagulants, Aspirin, Platelet Aggregation Inhibitors, Ticlopidine, Warfarin.
- chemical , analogs & derivatives : Ticlopidine.
- chemical , pharmacology : Anticoagulants, Aspirin, Platelet Aggregation Inhibitors, Ticlopidine, Warfarin.
- drug therapy : Aortic Diseases, Brain Ischemia, Embolism, Plaque, Atherosclerotic, Stroke.
- epidemiology : Aortic Diseases, Brain Ischemia, Embolism, Plaque, Atherosclerotic, Stroke.
- mortality : Aortic Diseases, Brain Ischemia, Embolism, Plaque, Atherosclerotic, Stroke.
- pathology : Aorta, Thoracic.
- Aged, Aged, 80 and over, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Prospective Studies, Single-Blind Method, Treatment Outcome.
Abstract
Severe atherosclerosis in the aortic arch is associated with a high risk of recurrent vascular events, but the optimal antithrombotic strategy is unclear.
DOI: 10.1161/STROKEAHA.113.004251
PubMed: 24699050
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003814
- to stream PubMed, to step Curation: 003700
- to stream PubMed, to step Checkpoint: 003700
- to stream Ncbi, to step Merge: 001935
- to stream Ncbi, to step Curation: 001935
- to stream Ncbi, to step Checkpoint: 001935
- to stream Main, to step Merge: 003B71
- to stream Main, to step Curation: 003B24
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.</title><author><name sortKey="Amarenco, Pierre" sort="Amarenco, Pierre" uniqKey="Amarenco P" first="Pierre" last="Amarenco">Pierre Amarenco</name><affiliation><nlm:affiliation>From the Department of Neurology, Stroke Centre, DHU FIRE, INSERM U 1148, Paris Diderot-Sorbonne University, Hôpital Bichat (P.A.), Department of Cardiology, Saint-Antoine Hospital and Medical School, Univeristé Pierre et Marie Curie (A.A.C.), and Department of Biostatistics, Paris-Diderot-Sorbonne University, Hôpital Bichat (C.L.), Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Neurology, Royal Melbourne Hospital (S.D.) and Florey Institute of Neuroscience and Mental Health (D.Y., M.M., G.A.D.), University of Melbourne, Melbourne, Australia; Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia (E.F.J.); Max Planck Institute for Neurological Research, Cologne, Germany (W.-D.H.); Department of Neurology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland (M.K.); Stroke and Ageing Research Centre, Monash University, Melbourne, Australia (D.Y.); and Division of Clinical Neurosciences, University of Edinburgh (SC005336), Scotland, United Kingdom (M.M.).</nlm:affiliation><wicri:noCountry code="subField">United Kingdom (M.M.).</wicri:noCountry></affiliation></author><author><name sortKey="Davis, Stephen" sort="Davis, Stephen" uniqKey="Davis S" first="Stephen" last="Davis">Stephen Davis</name></author><author><name sortKey="Jones, Elizabeth F" sort="Jones, Elizabeth F" uniqKey="Jones E" first="Elizabeth F" last="Jones">Elizabeth F. Jones</name></author><author><name sortKey="Cohen, Ariel A" sort="Cohen, Ariel A" uniqKey="Cohen A" first="Ariel A" last="Cohen">Ariel A. Cohen</name></author><author><name sortKey="Heiss, Wolf Dieter" sort="Heiss, Wolf Dieter" uniqKey="Heiss W" first="Wolf-Dieter" last="Heiss">Wolf-Dieter Heiss</name></author><author><name sortKey="Kaste, Markku" sort="Kaste, Markku" uniqKey="Kaste M" first="Markku" last="Kaste">Markku Kaste</name></author><author><name sortKey="Laouenan, Cedric" sort="Laouenan, Cedric" uniqKey="Laouenan C" first="Cédric" last="Laouénan">Cédric Laouénan</name></author><author><name sortKey="Young, Dennis" sort="Young, Dennis" uniqKey="Young D" first="Dennis" last="Young">Dennis Young</name></author><author><name sortKey="Macleod, Malcolm" sort="Macleod, Malcolm" uniqKey="Macleod M" first="Malcolm" last="Macleod">Malcolm Macleod</name></author><author><name sortKey="Donnan, Geoffrey A" sort="Donnan, Geoffrey A" uniqKey="Donnan G" first="Geoffrey A" last="Donnan">Geoffrey A. Donnan</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24699050</idno><idno type="pmid">24699050</idno><idno type="doi">10.1161/STROKEAHA.113.004251</idno><idno type="wicri:Area/PubMed/Corpus">003814</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003814</idno><idno type="wicri:Area/PubMed/Curation">003700</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003700</idno><idno type="wicri:Area/PubMed/Checkpoint">003700</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003700</idno><idno type="wicri:Area/Ncbi/Merge">001935</idno><idno type="wicri:Area/Ncbi/Curation">001935</idno><idno type="wicri:Area/Ncbi/Checkpoint">001935</idno><idno type="wicri:Area/Main/Merge">003B71</idno><idno type="wicri:Area/Main/Curation">003B24</idno><idno type="wicri:Area/Main/Exploration">003B24</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.</title><author><name sortKey="Amarenco, Pierre" sort="Amarenco, Pierre" uniqKey="Amarenco P" first="Pierre" last="Amarenco">Pierre Amarenco</name><affiliation><nlm:affiliation>From the Department of Neurology, Stroke Centre, DHU FIRE, INSERM U 1148, Paris Diderot-Sorbonne University, Hôpital Bichat (P.A.), Department of Cardiology, Saint-Antoine Hospital and Medical School, Univeristé Pierre et Marie Curie (A.A.C.), and Department of Biostatistics, Paris-Diderot-Sorbonne University, Hôpital Bichat (C.L.), Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Neurology, Royal Melbourne Hospital (S.D.) and Florey Institute of Neuroscience and Mental Health (D.Y., M.M., G.A.D.), University of Melbourne, Melbourne, Australia; Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia (E.F.J.); Max Planck Institute for Neurological Research, Cologne, Germany (W.-D.H.); Department of Neurology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland (M.K.); Stroke and Ageing Research Centre, Monash University, Melbourne, Australia (D.Y.); and Division of Clinical Neurosciences, University of Edinburgh (SC005336), Scotland, United Kingdom (M.M.).</nlm:affiliation><wicri:noCountry code="subField">United Kingdom (M.M.).</wicri:noCountry></affiliation></author><author><name sortKey="Davis, Stephen" sort="Davis, Stephen" uniqKey="Davis S" first="Stephen" last="Davis">Stephen Davis</name></author><author><name sortKey="Jones, Elizabeth F" sort="Jones, Elizabeth F" uniqKey="Jones E" first="Elizabeth F" last="Jones">Elizabeth F. Jones</name></author><author><name sortKey="Cohen, Ariel A" sort="Cohen, Ariel A" uniqKey="Cohen A" first="Ariel A" last="Cohen">Ariel A. Cohen</name></author><author><name sortKey="Heiss, Wolf Dieter" sort="Heiss, Wolf Dieter" uniqKey="Heiss W" first="Wolf-Dieter" last="Heiss">Wolf-Dieter Heiss</name></author><author><name sortKey="Kaste, Markku" sort="Kaste, Markku" uniqKey="Kaste M" first="Markku" last="Kaste">Markku Kaste</name></author><author><name sortKey="Laouenan, Cedric" sort="Laouenan, Cedric" uniqKey="Laouenan C" first="Cédric" last="Laouénan">Cédric Laouénan</name></author><author><name sortKey="Young, Dennis" sort="Young, Dennis" uniqKey="Young D" first="Dennis" last="Young">Dennis Young</name></author><author><name sortKey="Macleod, Malcolm" sort="Macleod, Malcolm" uniqKey="Macleod M" first="Malcolm" last="Macleod">Malcolm Macleod</name></author><author><name sortKey="Donnan, Geoffrey A" sort="Donnan, Geoffrey A" uniqKey="Donnan G" first="Geoffrey A" last="Donnan">Geoffrey A. Donnan</name></author></analytic><series><title level="j">Stroke</title><idno type="eISSN">1524-4628</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Anticoagulants (administration & dosage)</term><term>Anticoagulants (pharmacology)</term><term>Aorta, Thoracic (pathology)</term><term>Aortic Diseases (drug therapy)</term><term>Aortic Diseases (epidemiology)</term><term>Aortic Diseases (mortality)</term><term>Aspirin (administration & dosage)</term><term>Aspirin (pharmacology)</term><term>Brain Ischemia (drug therapy)</term><term>Brain Ischemia (epidemiology)</term><term>Brain Ischemia (mortality)</term><term>Drug Therapy, Combination</term><term>Embolism (drug therapy)</term><term>Embolism (epidemiology)</term><term>Embolism (mortality)</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Plaque, Atherosclerotic (drug therapy)</term><term>Plaque, Atherosclerotic (epidemiology)</term><term>Plaque, Atherosclerotic (mortality)</term><term>Platelet Aggregation Inhibitors (administration & dosage)</term><term>Platelet Aggregation Inhibitors (pharmacology)</term><term>Prospective Studies</term><term>Single-Blind Method</term><term>Stroke (drug therapy)</term><term>Stroke (epidemiology)</term><term>Stroke (mortality)</term><term>Ticlopidine (administration & dosage)</term><term>Ticlopidine (analogs & derivatives)</term><term>Ticlopidine (pharmacology)</term><term>Treatment Outcome</term><term>Warfarin (administration & dosage)</term><term>Warfarin (pharmacology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Accident vasculaire cérébral (mortalité)</term><term>Accident vasculaire cérébral (traitement médicamenteux)</term><term>Accident vasculaire cérébral (épidémiologie)</term><term>Acide acétylsalicylique (administration et posologie)</term><term>Acide acétylsalicylique (pharmacologie)</term><term>Adulte d'âge moyen</term><term>Antiagrégants plaquettaires (administration et posologie)</term><term>Antiagrégants plaquettaires (pharmacologie)</term><term>Anticoagulants (administration et posologie)</term><term>Anticoagulants (pharmacologie)</term><term>Aorte thoracique (anatomopathologie)</term><term>Association de médicaments</term><term>Embolie (mortalité)</term><term>Embolie (traitement médicamenteux)</term><term>Embolie (épidémiologie)</term><term>Encéphalopathie ischémique (mortalité)</term><term>Encéphalopathie ischémique (traitement médicamenteux)</term><term>Encéphalopathie ischémique (épidémiologie)</term><term>Femelle</term><term>Humains</term><term>Maladies de l'aorte (mortalité)</term><term>Maladies de l'aorte (traitement médicamenteux)</term><term>Maladies de l'aorte (épidémiologie)</term><term>Mâle</term><term>Méthode en simple aveugle</term><term>Plaque d'athérosclérose (mortalité)</term><term>Plaque d'athérosclérose (traitement médicamenteux)</term><term>Plaque d'athérosclérose (épidémiologie)</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Ticlopidine (administration et posologie)</term><term>Ticlopidine (analogues et dérivés)</term><term>Ticlopidine (pharmacologie)</term><term>Warfarine (administration et posologie)</term><term>Warfarine (pharmacologie)</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anticoagulants</term><term>Aspirin</term><term>Platelet Aggregation Inhibitors</term><term>Ticlopidine</term><term>Warfarin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Ticlopidine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anticoagulants</term><term>Aspirin</term><term>Platelet Aggregation Inhibitors</term><term>Ticlopidine</term><term>Warfarin</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Acide acétylsalicylique</term><term>Antiagrégants plaquettaires</term><term>Anticoagulants</term><term>Ticlopidine</term><term>Warfarine</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Ticlopidine</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Aorte thoracique</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Aortic Diseases</term><term>Brain Ischemia</term><term>Embolism</term><term>Plaque, Atherosclerotic</term><term>Stroke</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Aortic Diseases</term><term>Brain Ischemia</term><term>Embolism</term><term>Plaque, Atherosclerotic</term><term>Stroke</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Aortic Diseases</term><term>Brain Ischemia</term><term>Embolism</term><term>Plaque, Atherosclerotic</term><term>Stroke</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Accident vasculaire cérébral</term><term>Embolie</term><term>Encéphalopathie ischémique</term><term>Maladies de l'aorte</term><term>Plaque d'athérosclérose</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Aorta, Thoracic</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Acide acétylsalicylique</term><term>Antiagrégants plaquettaires</term><term>Anticoagulants</term><term>Ticlopidine</term><term>Warfarine</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Accident vasculaire cérébral</term><term>Embolie</term><term>Encéphalopathie ischémique</term><term>Maladies de l'aorte</term><term>Plaque d'athérosclérose</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Accident vasculaire cérébral</term><term>Embolie</term><term>Encéphalopathie ischémique</term><term>Maladies de l'aorte</term><term>Plaque d'athérosclérose</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term><term>Single-Blind Method</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Association de médicaments</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Méthode en simple aveugle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe atherosclerosis in the aortic arch is associated with a high risk of recurrent vascular events, but the optimal antithrombotic strategy is unclear.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Amarenco, Pierre" sort="Amarenco, Pierre" uniqKey="Amarenco P" first="Pierre" last="Amarenco">Pierre Amarenco</name><name sortKey="Cohen, Ariel A" sort="Cohen, Ariel A" uniqKey="Cohen A" first="Ariel A" last="Cohen">Ariel A. Cohen</name><name sortKey="Davis, Stephen" sort="Davis, Stephen" uniqKey="Davis S" first="Stephen" last="Davis">Stephen Davis</name><name sortKey="Donnan, Geoffrey A" sort="Donnan, Geoffrey A" uniqKey="Donnan G" first="Geoffrey A" last="Donnan">Geoffrey A. Donnan</name><name sortKey="Heiss, Wolf Dieter" sort="Heiss, Wolf Dieter" uniqKey="Heiss W" first="Wolf-Dieter" last="Heiss">Wolf-Dieter Heiss</name><name sortKey="Jones, Elizabeth F" sort="Jones, Elizabeth F" uniqKey="Jones E" first="Elizabeth F" last="Jones">Elizabeth F. Jones</name><name sortKey="Kaste, Markku" sort="Kaste, Markku" uniqKey="Kaste M" first="Markku" last="Kaste">Markku Kaste</name><name sortKey="Laouenan, Cedric" sort="Laouenan, Cedric" uniqKey="Laouenan C" first="Cédric" last="Laouénan">Cédric Laouénan</name><name sortKey="Macleod, Malcolm" sort="Macleod, Malcolm" uniqKey="Macleod M" first="Malcolm" last="Macleod">Malcolm Macleod</name><name sortKey="Young, Dennis" sort="Young, Dennis" uniqKey="Young D" first="Dennis" last="Young">Dennis Young</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B24 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003B24 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24699050
|texte= Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24699050" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |